Antibody to peptides of human myelin basic protein in post-rabies vaccine encephalomyelitis sera.
Development of neurologic complications after Semple rabies vaccine is closely linked to development of antibody to myelin basic protein (MBP). The portions of MBP against which the antibodies are directed were analyzed by enzyme immunoassay in sera and cerebrospinal fluid from 27 patients with vaccine complications. Most of the antibody was directed to regions of MBP peptides 45-89 and 90-170. There was no apparent correlation between antibody specificity for MBP peptides 1-44, 45-89 and 90-170 and the type of post-vaccinal neurologic complication. We conclude that the immunoglobulin repertoire in human B lymphocytes for responding to human MBP favors the portion of the MBP molecule containing residues 45-170.
Ubol
S
S
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore.
Hemachudha
T
T
Whitaker
J N
JN
Griffin
D E
DE
D000906:Antibodies / Q000276:immunology*; D004679:Encephalomyelitis / Q000097:blood / Q000209:etiology / Q000276:immunology*; D006801:Humans; D007124:Immunoenzyme Techniques; D004676:Myelin Basic Protein / Q000276:immunology*; D009422:Nervous System Diseases / Q000097:blood / Q000209:etiology / Q000276:immunology; D009479:Neuropeptides / Q000276:immunology*; D011819:Rabies Vaccines / Q000009:adverse effects* / Q000276:immunology
D000906:Antibodies; D004676:Myelin Basic Protein; D009479:Neuropeptides; D011819:Rabies Vaccines